SIC
KRRO icon

SJS Investment Consulting’s Korro Bio KRRO Stock Holding History

SJS Investment Consulting’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383 Buy
29
+7
+32% +$87 ﹤0.01% 2339
2026
Q1 		$250 Buy
+22
New +$242 ﹤0.01% 1935

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $508M AUM 163.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

SJS Investment Consulting's KRRO Position: Q2 2026 in Review

SJS Investment Consulting increased its Korro Bio (KRRO) stake by 32% in Q2 2026, buying an estimated $87 and bringing the position to 29 shares worth $383. The position accounts for ﹤0.01% of the portfolio, ranked #2339.

SJS Investment Consulting first reported a position in KRRO in Q1 2026 and has held it in 2 quarters since. 46 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • SJS Investment Consulting held 29 shares of Korro Bio worth $383 as of Q2 2026.
  • SJS Investment Consulting bought 7 Korro Bio shares in Q2 2026, an estimated $87.
  • Korro Bio made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2339 holding.
  • SJS Investment Consulting first reported a position in Korro Bio in Q1 2026 and has held it in 2 quarters since.
  • 46 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.